Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |